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Abstract
1
 
 
Dietary flavonoid quercetin has been suggested as a cancer chemopreventive agent, but the 
mechanisms of action remain unclear. This study investigated the influence of quercetin on p38-
MAPK and the potential regulation of the nuclear transcription factor erythroid-2p45-related factor 
(Nrf2) and the cellular antioxidant/detoxifying defense system related to glutathione (GSH) by p38 
in HepG2 cells. Incubation of HepG2 cell with quercetin at a range of concentrations (5-50μM) for 4 
or 18h induced a differential effect on the modulation of p38 and Nrf2 in HepG2 cells, showing 
50M quercetin the highest activation of p38 and values similar to those of control cells after 4 and 
18h treatment, respectively, together with the inhibition of Nrf2 at both incubation times. Quercetin 
(50M) induced a time-dependent activation of p38, which was in concert with a transient 
stimulation of Nrf2 to provoke its inhibition afterward. Quercetin also increased GSH content, 
mRNA levels of glutamylcysteine-synthetase (GCS) and expression and/or activity of glutathione-
peroxidase, glutathione-reductase and GCS after 4h of incubation, and glutathione-S-transferase 
after 18h of exposure. Further studies with the p38 specific inhibitor SB203580 showed that the p38 
blockage restored the inhibited Nrf2 transcription factor and the enzymatic expression and activity 
of antioxidant/detoxificant enzymes after 4h exposure. In conclusion, p38-MAPK is involved in the 
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mechanisms of the cell response to quercetin through the modulation of Nrf2 and glutathione-
related enzymes in HepG2 cells. 
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1. Introduction 
 
Quercetin (3, 3´, 4´, 5, 7-pentahydroxylflavone) is a flavonoid, one of the most abundant 
polyphenolic groups in plants (fruits and vegetables) [1], which can be extensively metabolized 
during absorption in the small intestine and in the liver [2, 3]. Many studies have demonstrated that 
quercetin exerts potential anticarcinogenic activities, since it is a potent inhibitor of tumor initiation 
in vivo [4], is a powerful radical scavenger able to prevent or delay conditions which favor cellular 
oxidative stress [5, 6], possesses anti-proliferative activities against tumor cells in vitro [4, 7, 8], 
and induces apoptosis in different cancer cell lines by modulating a number of key elements in 
cellular signal transduction pathways linked to the apoptotic cell death [1, 7-12]. 
Two possible mechanisms have been suggested to explain the chemoprotective effects of quercetin. 
The first includes the removal of preinitiated cells from damaged tissues through cell cycle arrest 
and apoptosis [10-13]. Alternatively, the modulation of metabolizing enzymes has been proposed as 
another chemopreventive mechanism that can block carcinogen activation (inhibition of 
cytochrome P450) or enhance the detoxification of activated carcinogens (activation of phase II 
detoxifying enzymes) [14]. Thus, quercetin is found to interact with the cellular defense system 
such as NADPH:quinone oxidoreductase, iNOS, monooxygenase, COX, xanthine oxidase, 
lipoxygenase, hemeoxygenase-1, etc. [8, 15-17]. In this regard, the induction of 
antioxidant/detoxifying enzymes as well as glutathione (GSH) levels provides significant biological 
mechanisms for protection against toxic effects of endogenous reactive oxygen species (ROS) and 
exogenous carcinogens and/or their reactive intermediates [16, 18-22]. 
Nuclear factor-erythroid 2p45-related factor-2 (Nrf2) plays a central role in the induction of 
antioxidant and detoxifying enzymes through its binding to the antioxidant response element (ARE) 
[23, 24]. Nrf2 is sequestered in the cytoplasm as an inactive complex with its cytosolic repressor 
Kelch-like ECH associated protein-1 (Keap-1). The dissociation of Nrf2 from Keap-1 is crucial for 
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its nuclear translocation, followed by binding to DNA and activation of cytoprotective genes [23]. 
To date, multiple signaling kinases related to cell survival/proliferation have been reported to 
regulate Nrf2, which include extracellular signal-regulated kinase (ERK), c-jun NH2-terminal 
kinase (JNK), phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) [21, 23]. Indeed, the 
phosphorylation of Nrf2 by these different kinases at multiple sites seems to be an important 
mechanism in Nrf2-mediated ARE activation and in regulating the stability of this transcription 
factor [25], but few data have been reported about Nrf2 regulation and p38 MAPK. 
p38 MAPK consists of four isoforms: p38, p38, p38 and p38. p38 is the most abundant and 
ubiquitously expressed family protein and has a well established role in stress response and 
inflammation [26]. Once p38-MAPK is phosphorylated and activated, it phosphorylates and/or 
activates downstream substrates (kinases, transcriptional factors, etc.), resulting in various cellular 
responses such as proliferation, apoptosis, cell cycle arrest, and inflammation [26]. In line with this, 
up-regulation of the hemeoxygenase-1 detoxification enzyme via Nrf2 has been reported to involve 
p38-MAPK in renal cells [27]. Similarly, Yao et al [17] have demonstrated that p38 and ERK 
mediated quercetin-derived Nrf2 translocation into nuclei and subsequent induction of 
hemeoxygenase-1 activity. 
Although different studies have consistently demonstrated that quercetin is a strong inducer of GSH 
content and antioxidant/detoxificant enzymes, the detailed upstream signaling mechanisms are still 
unclear. In the present study, quercetin modulation of p38 in relation to Nrf2 function and the role 
of p38 on the regulation of cellular antioxidant/detoxifying defense system related to glutathione 
have been analyzed. 
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2. Materials and methods 
 
2.1. Materials and chemicals 
Quercetin, SB203580, cycloheximide (CHX), gentamicin, penicillin G and streptomycin were 
purchased from Sigma Chemical (Madrid, Spain). Anti-phospho-p38 recognizing phosphorylated 
Thr180/Tyr182 (9216) and anti--actin (4697) were obtained from Cell Signalling Technology 
(Izasa, Madrid, Spain). Anti-p38 (sc-535), anti-Nrf2 (C-20, sc-722), anti-Nrf2 (H-300, sc-13032), 
anti-PARP (sc-7150) and anti-GRB2 (sc-255) were purchased from Santa Cruz Biotechnology Inc. 
(Santa Cruz, CA, USA). Materials and chemicals for electrophoresis were from BioRad (BioRad 
Laboratories S.A., Madrid, Spain). Cell culture dishes and cell culture medium were from Falcon 
(Cajal, Madrid, Spain) and Biowhittaker Europe (Lonza, Madrid, Spain), respectively.  
 
2.2. Cell culture and quercetin treatment 
Human hepatoma HepG2 cells were grown in DMEM F-12 medium from Biowhitaker (Lonza, 
Madrid, Spain), supplemented with 2.5% Biowhitaker fetal bovine serum (FBS) and the following 
antibiotics: gentamicin, penicillin and streptomycin (50 mg/L). Cells were maintained at 37ºC in a 
humidified atmosphere of 5% CO2. 
Cells were seeded and routinely grown in DMEM-F12 medium and 2.5% FBS, but they were 
changed to serum-free medium 24 h before the assay in order to avoid the influence of the growth 
factors contained in the FBS on the results. To study the time-course effects of quercetin, cells were 
treated with 50 µM quercetin and then harvested at different times (0, 10, 30, 60, 120, 240 and 1080 
min). 
In the experiments with quercetin and the selective pharmacological inhibitor of p38, cells were 
preincubated with SB203580 (10 µM) for 2 h prior to 50 µM quercetin treatment for 240 min or 
1080 min. 
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To analyze the effect of quercetin and p38 inhibition on Nrf2 stabilization, HepG2 cells were 
incubated with SB203580 for 2 h before incubating with 50 µM quercetin for 1080 min and then 
treated with 100 µg/mL CHX for 1 h. 
 
2.3. Fluorescence microscopy 
Fluorescence assay was performed as previously described [28]. Briefly, HepG2 cells were seeded 
(25.000 cells/well) on glass coverslips with DMEM F-12 supplemented with FBS for 24 h and 
changed to serum-free medium 24 h before the assay. After incubation with quercetin for the 
indicated times, cells were washed with PBS at room temperature and then fixed with 3.7% 
paraformaldehyde for 10 min at room temperature. Nuclei were visualized by using DAPI staining. 
The coverslips were mounted in Vectashield and images were taken with a Zeiss Axiovert 200M 
fluorescence microscope (Carl Zeiss Microimaging GmbH, Munich, Germany) at 63x 
magnification. AxioVisionRel 4.6 software was used for the analysis of the images obtained. 
 
2.4. Preparation of total cell lysates 
To detect p38 and phospho-p38, cells were lysed at 4ºC in a buffer containing 25 mM HEPES (pH 
7.5), 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol (DTT), 0.1% Triton X-
100, 200 mM β-glycerolphosphate, 0.1 mM Na3VO4, 2 µg/mL leupeptin and 1mM 
phenylmethylsulfonyl fluoride (PMSF). The supernatants were collected, assayed for protein 
concentration by using the Bio-Rad (Bio-Rad, Madrid, Spain) protein assay kit according to the 
manufacture´s specifications, aliquoted and stored at -80ºC until used for Western blot analyses. 
 
2.5. Preparation of nuclear and cytosolic extracts 
To analyze Nrf2, cells were resuspended at 4ºC in 10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM 
KCl, 0.5 mM DTT, 0.2 mM PMSF (buffer A), allowed to swell on ice for 10 min, and then 
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vortexed for 10s. Samples were centrifuged at 10,000 g for 2 min and the supernatant containing the 
cytosolic fraction was stored at -80°C. The pellet was resuspended in cold buffer B (20 mM HEPES 
pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM 
PMSF, 2.5 µg/mL leupeptin, 2.5 µg/mL aprotinin) and incubated on ice for 20 min for high salt 
extraction. Cellular debris was removed by centrifugation at 13,000 g for 10 min at 4°C, and the 
supernatant fraction containing nuclear protein extract was stored at -80°C. Proteins were measured 
using the Bradford reagent (Bio-Rad, Madrid, Spain) following the recommendations of the 
supplier. 
 
2.6. Western blot analysis 
Equal amounts of proteins (100 µg) were separated by SDS-polyacrylamide gel electrophoresis and 
transferred to polyvinylidene difluoride (PVDF) filters (Protein Sequencing Membrane, Bio-Rad, 
Madrid, Spain). Membranes were probed with the corresponding primary antibody followed by 
incubation with peroxide-conjugated anti-rabbit immunoglobulin (GE Healthcare, Madrid, Spain) 
or peroxide-conjugated anti-mouse immunoglobulin only for p-p38 (Sigma, Madrid, Spain). Blots 
were developed with the ECL system (GE Healthcare, Madrid, Spain). Antigrowth factor receptor-
bound protein-2 (anti-GRB2) and anti-poly(ADPribose) polymerase (anti-PARP) antibodies were 
used as markers for the cytosolic and nuclear extracts, respectively. Normalization of Western blot 
was ensured by β-actin and bands were quantified using a scanner and accompanying software. 
 
2.7. Measurement of the Nrf2 DNA binding activity 
The DNA binding of Nrf2 was measured with a colorimetric non-radioactive Nrf2 Transcription 
Factor ELISA Assay (Active Motif, Rixensart, Belgium) according to the manufacturer’s 
instructions. Briefly, nuclear extracts were incubated in the oligonucleotide-coated wells. Then, 
wells were washed and incubated with the antibody against Nrf2. Addition of the secondary 
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antibody conjugated to horseradish peroxidase provided a colorimetric readout. The absorbance of 
each well was measured using a microplate reader at 450 nm (Bio-Tek, Winooski, VT, USA). 
 
2.8. Cell viability assay 
Cell viability was determined using the crystal violet assay [11]. HepG2 cells were seeded at low 
density (10
4
 cells per well) in 96-well plates, grown for 20 h and incubated with crystal violet (0.2% 
in ethanol) for 20 min. Plates were rinsed with water, allowed to dry, and 1% sodium dodecylsulfate 
(SDS) added. The absorbance of each well was measured using a microplate reader at 570 nm (Bio-
Tek, Winooski, VT, USA). 
 
2.9. RNA semiquantitation by reverse transcriptase-polymerase chain reaction 
Total RNA from cultured HepG2 cells was extracted by RNeasy kit (Qiagen, IZASA, Barcelona, 
Spain). One microgram of total RNA was used for reverse transcription polymerase chain reaction 
(RT-PCR) analysis. PCR was performed using the following couples of primers: 5′-
TCCGCTGCAAATACATCTCC-3′ and 5′-TGTTTCCCGTTGCCATTGAT-3′ (Ta=55ºC) for 
glutathione S-transferase (GST); 5′-GGCACAGGTAAAACCAAATAGTAAC-3′ and 5′-
CAAATTGTTTAGCAAATGCAGTCA-3′ (Ta=55ºC) for glutamylcysteine synthetase (GCS); 5′-
CAGTGGGACTCACGGAAGAT-3′ and 5′-TTCACTGCAACAGCAAAACC-3′ (Ta=52ºC) for 
glutathione reductase (GR); 5′-CCTCAAGTACGTCCGACCTG-3′ and 5′-
TAGGAGTTGCCAGACTGCTG-3′ (Ta=58ºC) for glutathione peroxidase (GPx). Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene. Samples were incubated in 
an automated heat block (PCR express system, Thermo Hybaid, Middlesex, UK). The PCR 
products were electrophoresed on a 1.5% agarose gel containing ethidium bromide. Densitometric 
analysis was performed using a scanner and accompanying software. Band intensity was 
normalized to values for GAPDH that was used as an internal control. 
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2.10. Determination of reduced glutathione (GSH) 
The content of GSH was quantified by the fluorometric assay of Hissin and Hilf [29]. The method 
takes advantage of the reaction of GSH with o-phtalaldehyde at pH 8.0. After the different 
treatments, cells (4x10
6
) were detached and homogenized by ultrasound with 5% trichloroacetic 
acid containing 2 mM EDTA. Following centrifugation of cells for 30 min at 1,000 g, 50 µL of the 
clear supernatant was transferred to a 96-multiwell plate for the assay. Fluorescence was measured 
at an excitation wavelength of 340 nm and an emission wavelength of 460 nm. The results of the 
samples were referred to those of a standard curve of GSH. The precise protocol has been described 
elsewhere [5, 6]. 
 
2.11. Determination of GPx and GR activities 
Treated cells were collected in PBS and centrifuged at 300 g for 5 min. Cell pellets were 
resuspended in 20 mM Tris containing 5 mM EDTA and 0.5 mM mercaptoethanol, sonicated and 
centrifuged at 3,000 g for 15 min. Enzymatic activities were measured in the supernatants. The 
determination of the GPx activity is based on the oxidation of GSH by GPx, using 30 mM tert-
butylhydroperoxide as a substrate, coupled to the disappearance of NADPH by GR [30]. A cuvette 
containing assay buffer plus 0.1 M GSH, 50 U/mL GR and 9.6 mM NADPH was used to blank the 
spectrophotometer prior to addition of the sample and 30 mM tert-butyl hydroperoxide. 
Additionally, a sample with cells treated with 400 μM tert-butylhydroperoxide for 3 hours was used 
as an internal positive control for GPx overactivity (data not shown) [5]. GR activity was 
determined by following the decrease in absorbance due to the oxidation of NADPH utilized in the 
reduction of oxidized GSH [31]. Each sample was blanked at the spectrophotometer in the presence 
of assay buffer plus 15 mM EDTA and 65 mM oxidated glutathione prior to addition of 9.6 mM 
NADPH. As for GPx activity, a sample with cells treated with 400 μM tert-butylhydroperoxide for 
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3 hours was used as an internal positive control for GR overactivity (data not shown) [5]. Protein 
was measured by the Bradford reagent (Bio-Rad, Madrid, Spain). 
 
2.12. Determination of GST activity 
GST activity was determined using a commercial fluorimetric activity assay kit (Biovision 
Research Products, CA, USA). Treated cells were collected in PBS and centrifuged at low speed 
(300 g) for 5 min. Cell pellets were resuspended in sample buffer, sonicated and centrifuged at 
3,000 g for 15 min and enzyme activity was measured in the supernatants. The assay utilizes 
monochlorobimane (MCB) as an artificial substrate and glutathione to determine total GST activity. 
GST catalyses the MCB-glutathione reactions and the fluorescence levels are proportional to the 
amount of GST present in the reaction medium. A fluorescent microplate reader at an excitation 
wavelength of 380 nm and an emission wavelength of 460 nm was used (Bio-Tek, Winooski, VT, 
USA). The results of the samples were referred to those of a standard curve of GST activity, and the 
GST standard was provided by the commercial kit. Protein was measured by the Bradford reagent. 
 
2.13. Statistics 
Prior to statistical analysis, data were tested for homogeneity of variances by the test of Levene; for 
multiple comparisons, one-way ANOVA was followed by the Bonferroni test when variances were 
homogeneous or by the Tamhane test when variances were not homogeneous. P<0.05 was 
considered significant. A SPSS version 17.0 program was used. 
 12 
3. Results 
 
3.1. Dose-effect of quercetin on Nrf2 and p38 
To investigate whether quercetin treatment in HepG2 cells was able to regulate key proteins related 
to the cellular response to chemical/oxidative stress [23, 26], p38-MAPK and Nrf2 protein 
expressions were analyzed. HepG2 cells were treated with 5-50 μM quercetin for 4 and 18 h, as 
short- and long-term treatments, in order to study the regulatory effect of the flavonoid on p38-
MAPK and the antioxidant defense system both in potential non-toxic and toxic conditions, 
respectively. Figures 1A and 1B illustrate that a 4 h treatment with 10-50 μM quercetin increased 
the phosphorylated levels of p38 in HepG2 cells. In addition, 18 h of incubation with 5-25 μM 
flavonoid induced the phosphorylation of p38, whereas 50 μM quercetin showed comparable levels 
of phosphorylated p38 to those of control cells. Likewise, there was no difference in the total levels 
of p38. 
Similarly, it was investigated whether quercetin treatment was able to regulate the transcription 
factor Nrf2 in HepG2 cells. No phosphorylated Nrf2 (100 kDa) was detected in the cytosolic 
fraction of HepG2 cells, as previously shown [28]. A 4h-treatment with 10 and 25 μM quercetin 
significantly increased the nuclear translocation of Nrf2 (57 kDa) and the nuclear content of 
phosphorylated Nrf2 (100 kDa), whereas 50 μM quercetin decreased both the Nrf2 phosphorylated 
levels and the nuclear/cytosolic Nrf2 ratio (Figures 1C-1E). On the other hand, a 18 h treatment 
with 5-10 μM quercetin increased the nuclear translocation of Nrf2 (57 kDa) and the nuclear 
content of phosphorylated Nrf2 (100 kDa), and both parameters decreased in the presence of 50 μM 
quercetin. The integrity of the cytosolic and nuclear fractions was confirmed by the analysis of the 
compartment-specific cytosolic GRB2 and nuclear PARP proteins. These results suggest that the 
duration of the treatment and the concentration of quercetin have a prominent effect on the 
modulation of p38 and Nrf2 in HepG2 cells. 
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Given that 50 μM quercetin was the concentration that provoked the strongest induction of p38 after 
4 h of treatment returning the phosphorylated levels of p38 to control values after 18h of incubation, 
and showed an inhibitory effect on Nrf2 at both incubation times, this was the concentration 
selected for studying the contribution of p38 to the modulation of Nrf2 by quercetin in HepG2 cells. 
 
3.2. Subcellular localization of quercetin 
By using the fluorogenic properties of quercetin, the cellular localization of the flavonoid was 
studied upon its internalization, HepG2 cells were treated for different times with 50 M quercetin. 
Cell incubation resulted in a yellow-green fluorescent signal that was detected in a fluorescence 
microscope upon excitation at 350-525 nm and emission at 475-625 nm (Figure 2). The fluorescent 
signal of quercetin was mainly located in the nucleus of HepG2 cells as early as after 10min of 
incubation (Figure 2). The signal was observed up to 240 min of treatment and only after the 
longest incubation time (1080 min) was not detected (Figure 2). These results indicated that 
quercetin exhibited specific fluorescence and showed mainly a nuclear localization in HepG2 cells. 
 
3.3. Quercetin activates p38 in a time-dependent manner 
The activation of p38-MAPKs has traditionally been associated with the stress response and some 
apoptotic processes, although p38-MAPKs have also been implicated as positive regulators in cell 
survival [26]. Since variations in the phosphorylated levels of p38 could occur in a time-dependent 
manner, it was important to study the effect induced by quercetin on this protein through the time in 
HepG2 cells. To this end, total and phosphorylated (active form) protein expressions of p38 were 
analyzed. Treatment of HepG2 cells with quercetin resulted in an enhanced phosphorylation of p38 
at 10-240 min, returning to control levels at the longest time tested (18 h) (Figures 3A and 3B). 
Total p38 protein levels did not change during quercetin exposure. 
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3.4. Time-course effect on Nrf2 modulation induced by quercetin 
Nrf2 is involved in the response to chemical/oxidative stress [23]. To assess the implication of Nrf2 
on quercetin effects, time-course studies on the nuclear and cytosolic levels of this transcription 
factor were performed. Quercetin concurrently increased nuclear translocation of Nrf2 (57 kDa) and 
nuclear content of phosphorylated Nrf2 (100 kDa) at 60 min of treatment, followed by a decrease at 
240 min of quercetin exposure (Figures 4A-4C). This effect remained up to 1080 min of incubation 
as can be deduced from the decline in the nuclear phosphorylated content and nuclear/cytosolic 
ratio of Nrf2 (Figures 4A-4C). Therefore, quercetin early and transiently activates Nrf2 
translocation to later decrease its mobilization. 
To further investigate the time-course effect of quercetin on the Nrf2 regulation, Nrf2 DNA-binding 
activity was studied. Quercetin induced a transient increase of Nrf2 binding activity (60 min), and 
later showed a reduced binding activity (240 and 1080 min) (Figure 4D). The profile of the effect 
on Nrf2 binding activity was similar to that observed for the nuclear phosphorylated content and 
nuclear/cytosolic ratio of this transcription factor (Figure 4A-4C). Thus, as previously suggested 
quercetin activated Nrf2 and DNA binding early and transiently to later induce the inhibition of this 
transcription factor. 
 
3.5. Role of p38 in quercetin-induced effects on cell viability and Nrf2 
To elucidate the contribution of p38 to the modulation of Nrf2 by quercetin, the effects of 
SB203580 a specific inhibitor of p38 were evaluated. HepG2 cells were previously exposed to 
SB203580 and then treated with 50 M quercetin during 4 or 18 h. 
First, the potential cytotoxicity was studied in these experimental conditions. Treatment of HepG2 
cells with SB203580 followed by addition of quercetin did not modify cell viability after 4 h of 
incubation (Table 1). The reduced percentage of viable cells was partly restored by the selective 
blockade of p38 with SB203580 inhibitor after 18 h of quercetin treatment (Table 1). 
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In addition, in quercetin-treated cells the selective blockade of p38 completely restored to control 
levels the Nrf2 phosphorylated values and the ratio of nuclear versus cytosolic Nrf2 levels after 4 h 
of incubation (Figures 5A-5C), whereas at 18 h of treatment a partial recovery in both Nrf2 
phosphorylated levels and nuclear/cytosolic Nrf2 ratio was observed (Figures 5E-5G). These results 
suggested that p38 is involved in the modulation of Nrf2 induced by quercetin, as the inhibition of 
p38 completely or partly reverted the flavonoid-induced effects on Nrf2 depending on the length of 
the exposure to quercetin. In addition, cell viability was restored in part after 18 h of incubation 
with quercetin by inhibiting p38-MAPK. 
Nrf2 DNA-binding activity was also studied after the inhibition of p38 by using SB203580. 
Q+SB203580 treated cells recovered the Nrf2 binding activity to control values after 4 h of 
incubation (Figure 5D), as occurred with the Nrf2 phosphorylated values and nuclear/cytosolic ratio 
(Figures 5A-5C). In addition, the decreased Nrf2 DNA-binding activity in quercetin-treated cells 
after 18 h resulted in a slight recovery on the Nrf2 DNA-binding activity when incubating cells with 
quercetin and SB203580 (Figure 5H). Comparable effects were observed for the Nrf2 
phosphorylated values and the nuclear/cytosolic ratio after treating cells with quercetin (50 μM) and 
SB203580 for 18 h (Figures 5E-5G). These data indicated that quercetin effects on Nrf2 binding 
activity were totally or moderately restored, depending on the duration of the treatment when p38 is 
inhibited. 
 
3.6. p38 inhibition stabilize Nrf2 
To clarify whether p38 inhibition contributes to the stimulation of the transcription factor by 
stabilizing Nrf2 protein, cells were pretreated with SB203580 for 2 h before incubating with 50 µM 
quercetin during 1080 min and then treated with the inhibitor of protein synthesis CHX for 1 h. The 
quercetin-decreased nuclear/cytosol ratio of Nrf2 was partly restored by the inhibition of p38, 
whereas additional treatment with CHX evoked comparable levels to those of untreated cells 
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(Figure 6). These results revealed that the inhibition of p38 pathway seems to contribute to stabilize 
Nrf2 protein levels. 
 
3.7. Quercetin modulates GSH levels and antioxidant/detoxificant enzymatic activities. Role of p38 
Studies on the antioxidant enzyme induction by oxidative stress stimuli have shown that Nrf2 also 
plays a main part and that PI3K and ERK-MAPK pathways seem to be involved in the transduction 
of signals initiating gene activation [23]. To further address whether a similar mechanism is 
responsible for the regulation of the GSH and the activities of antioxidant/detoxifying enzymes 
induced by quercetin, the effect of the p38 inhibitor was assayed. 
GSH concentration was evaluated as an index of the intracellular non-enzymatic antioxidant 
defenses. After 4 h treatment, 50 M quercetin evoked an increase in the concentration of GSH, 
whereas pretreatment with the p38 inhibitor returned the quercetin-enhanced GSH values to similar 
levels to those of untreated cells (Figure 7A). Quercetin alone or in combination with SB203580 did 
not induce any change in the GSH levels after 18 h of incubation (Figure 7A). 
As shown in Figure 6B, pretreatment with SB203580 returned the quercetin-induced activity of 
GPx after 4 or 18 h of incubation to control values. Similarly, quercetin-induced GR activity was 
suppressed by SB203580 pretreatment after 4 or 18 h of incubation (Figure 7C). After 18 h of the 
flavonol exposure, GST activity was enhanced, but the activity of this detoxifying enzyme remained 
unchanged after 4 h of treatment with quercetin (Figure 7D). Moreover, the p38 inhibitor did not 
affect GST activity at both tested times when compared to quercetin-treated cells (Figure 7D). 
These results illustrated that the p38 pathway seems to be involved in the quercetin-induced 
activation of cellular antioxidant/detoxificant defenses. 
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3.8. Involvement of p38 in quercetin-regulated antioxidant/detoxificant enzymatic gene expressions 
The effect of 50 μM quercetin on glutathione-related enzymes gene expression was further 
examined. The increased GPx mRNA expression induced by quercetin treatment (4 h) was reverted 
to control levels by the exposure to the p38 inhibitor (Figures 8A and 8B). On the other hand, after 
18h of treatment, quercetin did not modify the expression of GPx, and its mRNA levels remained 
also unchanged in cells incubated with the p38 inhibitor in comparison to untreated cells (Figures 
8C and 8D). Pretreatment with SB203580 suppressed both the increased mRNA expression of GR 
and GCS at 4 h of incubation (Figures 8A and 8B). However, the expression levels of GCS and GR 
were unaltered in the presence of quercetin and/or the p38 inhibitor after 18 h of incubation, 
showing similar values to those of control cells (Figures 8C and 8D). Conversely, SB203580 
significantly inhibited the quercetin-induced mRNA expression of GST (18 h), whereas cells treated 
for 4 h either with quercetin alone or in combination with the p38 inhibitor did not show any 
modification on GST gene expression when compared to control cells (Figures 8A and 8B). All 
these results suggested an involvement of p38 pathway in the quercetin-induced modulation of 
GSH-related antioxidant/detoxificant enzymes at 4 h, although the defensive regulatory 
mechanisms seem to be attenuated through the time. 
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4. Discussion 
 
There has been a recent surge in interest in phytochemicals as medicinal anticancer agents due to 
their potential favorable efficacy [1]. Quercetin is consumed in the diet and a large body of 
evidence indicates that it has potent chemopreventive effects against a variety of malignant cell 
lines and in murine carcinoma models [4, 7, 10]. 
Quercetin daily intake ranges between 5-40 mg/day, but it has been estimated that its daily ingestion 
can reach 200-500 mg/day in people with a high intake of fruit and vegetables [32]. Published data 
on quercetin pharmacokinetics in humans suggest that a dietary supplement of 1-2 g of quercetin 
may result in plasma concentrations ranging between 10-50 μM [33]. In addition, it has been 
reported that after administration of quercetin in high doses, its metabolism mainly takes place in the 
liver instead of the small intestine [3]. In plasma, the main quercetin metabolites found are sulphated 
and glucuronidated derivatives, as well as O-methylquercetin and 3'-O-methylquercetin-3-O-
glucuronide [32]. In addition, quercetin degradation by the microflora produces different phenolic 
acids, which are mainly 3,4-dihydroxyphenylacetic, 3-methoxy-4-hydroxyphenylacetic 
(homovanillic acid), and 3-hydroxyphenylacetic acid [32]. However, at present the potential 
contribution of quercetin metabolites to the biological activity is unclear and it should not be 
underestimated; its evaluation will require further studies. 
In the present study, it is demonstrated that quercetin differently modulates p38 and Nrf2 depending 
on the concentration used and the length of the treatment. Thus, 50 μM quercetin regulates GSH-
related antioxidant/detoxifying enzymes and Nrf2 by targeting p38-MAPK. Quercetin rapidly 
activates Nrf2 by up-regulating the phosphorylation and translocation of Nrf2 to later inhibit both 
effects and in parallel also transiently induces p38-MAPK activation. These actions caused by 
quercetin seem to play an important role both in the regulation of important glutathione-related 
enzymes and in the final induction of cell death. 
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The intracellular biotransformation of quercetin by HepG2 cells was evidenced by the gradual 
disappearance of its intrinsic fluorescence. However, it should be considered that quercetin and/or 
its metabolites could contribute to the observed fluorescence. This signal of fluorescence was 
mainly located in the nucleus after a short incubation time, in agreement with Nifli et al. [34], 
suggesting that quercetin internalization is coupled to its transient binding to specific target 
proteins. 
Activation of p38-MAPK has been positively related to cell survival and more traditionally to the 
stress response and apoptosis, and its role in the programmed cell death depends on the cell type 
and the stimuli [26]. Consequently, p38-MAPK may act as a mediator of apoptosis in fibroblasts 
[35], cardiomyocytes [35] and in hepatic cells [36]. Thus, quercetin-induced activation of p38 could 
be associated to the up-regulation of proapoptotic proteins and down-regulation of survival 
pathways, which would lead to cell death, in agreement with the present and previous studies [10-
12, 35]. 
Nrf2 seems to have an important role in the protection against induced liver injury [23, 37]. Thus, 
Nrf2 regulates the response to cellular stress and cell survival/proliferation [8, 37-39]. In line with 
this, it has been demonstrated that polyphenols alone, as well as a few glycosylated such as 
quercitrin, could activate Nrf2 [8, 16, 17, 24, 28], which is in agreement with the present study. 
Nrf2 phosphorylation has been described as a critical event for the nuclear translocation of this 
transcription factor and its transcriptional activity [23, 25, 28]. Moreover, Nrf2 DNA-binding 
activity could be linked to the nuclear phosphorylated Nrf2 levels (100 kDa) described in the 
present study. 
Nrf2 may also define the initial threshold for toxicity by controlling, at least in part, constitutive 
aspects of cell defense [24, 37, 38]. In this regard, it has been described that an agent could 
stimulate the nuclear accumulation of Nrf2 at non-cytotoxic concentrations or after a short time of 
incubation, although it could induce significant cytotoxicity at longer times of exposure [37]. 
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Therefore, the Nrf2-ARE pathway could act as a sensor and respond to chemical stress before the 
onset of the cytotoxicity. In line with this, it could be suggested that Nrf2 is activated in response to 
mild and acute quercetin treatment as an adaptive response to guard against oxidative and 
inflammatory cell damage, but Nrf2 might not play a protective role against long and cytotoxic 
flavonoid exposure. 
Post-translational modification of Nrf2 by various protein kinase signaling pathways can affect its 
nuclear translocation. ERK, JNK, PI3K and PKC are some of the kinases identified as responsible 
for Nrf2 phosphorylation [23]. However, the effect of p38 on Nrf2 seems to be controversial, as it 
has been reported that Nrf2 activation could be attenuated by the overexpression of p38-MAPKs 
[39, 40]. On the contrary, it has also been described that p38 activation leads to ARE induction [41, 
42]. A possible explanation for these different findings is that while certain ARE inducers may 
activate p38-MAPK, others may inhibit p38-MAPK [43]. In line with this, quercetin has been 
reported to upregulate Nrf2 through the activation of both its transcription and post-transcription 
modifications [16]. In the present study, it seems that Nrf2 is regulated by posttranslational 
alterations since the use of p38-MAPK pathway inhibitor increases the stability of Nrf2, as 
previously shown [43]. 
The capacity of cells to maintain homeostasis during oxidative stress resides in the induction of 
protective enzymes, as well as non-enzymatic defenses such as GSH [5, 7, 8, 18-20, 22, 44], 
playing Nrf2 an important role in the regulation of these processes [8, 16, 21, 24]. 
Consequently, the enhancement of GSH concentration and glutathione-related enzymes seem to 
prepare cells to prevent a potential oxidative insult and suppress oxidative-stress induced damage 
[5, 6, 19, 21, 22, 45]. Consistent with this, our results revealed that 4 and 18 h treatment of HepG2 
cells with quercetin increased the activity of GPx and GR, as well as GSH content after 4 h of 
incubation. In this regard, an increase in GSH concentration induced by quercetin has been 
previously found in HepG2 cells and in the liver [6, 17, 46]. Furthermore, the enhancement in GPx 
 21 
and GR enzyme activities after 4 h of treatment was correlated with a parallel augment in their 
mRNA levels, as well as GCS expression, suggesting that quercetin can modulate GSH-related 
enzymes gene expression as previously described for quercetin and other phenolic compounds [18, 
46]. Interestingly, the enhanced activities of GPx and GR were not accompanied by increased 
mRNA levels after 18 h of quercetin exposure, and similar values to untreated cells were observed 
in these conditions. This feature could be related to the fact that the Nrf2 activation occurs as an 
early event; in addition, the elevated GPx activity has been observed after submitting HepG2 cells 
to oxidative challenges [19, 44], and an augmented GR activity has been related to an enhancement 
in the metabolism of the xenobiotic and flavonoids [14, 44]. Similarly, after an acute stress GSH 
levels could be temporally decreased and later recovered due to an increase in GCS activity and 
mRNA [46]; this has been considered as an indication of a cellular self-protection against a sub-
lethal toxic insult [14]. All these results suggest that the final cytotoxicity associated to quercetin 
treatment and the unchanged levels of mRNA expression for GPx, GR and GCS (18 h) might imply 
impairment in the machinery involved in gene transcription and mRNA synthesis of the antioxidant 
enzymes. In fact, cell death caused by quercetin may indicate that the toxic insult has overwhelmed 
the defense mechanisms, such as Nrf2 response, as previously shown for other agents [38]. In line 
with this, it has been reported the activation of Nrf2 and related genes to this transcription factor in 
cells undergoing apoptosis, suggesting that the treatment with dietary polyphenolic might not be 
enough to protect against cell death [24]. 
The detoxification enzyme GST catalyses the reaction of endogenous GSH with numerous 
electrophiles to yield less toxic conjugates and facilitate their elimination [18]. GST activity and 
mRNA expression increased after 18 h of treatment with quercetin. Different natural compounds, 
and also quercetin and its glycosylated form, induce GST activity as a mechanism of protection 
against oxidative stress [8, 18, 19, 45, 47]. On the other hand, a number of studies have shown a 
correlation between overexpression of GST and the development of resistance towards various 
 22 
anticancer drugs [48]. Thereby, induction of GST may not be favorable for cancer chemotherapy 
and a significant inverse correlation has been demonstrated between GST enzyme activity and 
tumor incidence [45, 49]. In this line, it has been recently reported that epigallocatechin-3-gallate 
and sulforaphane augment Nrf2 and detoxifying enzyme levels, which has been associated with a 
chemoresistance to cytotoxic drugs [50]. However, other authors suggest that the effect of 
polyphenols on GST activity may depend on the amount of phenolic compound incorporated into 
the cells [47]. In any case, it should be highlighted that many researches have shown that quercetin 
possesses anticancer effects on different models through different mechanisms [1, 10, 14]. Taken all 
these results together, it could be proposed that the increased endogenous defense capacity evoked 
by quercetin could be a critical determinant in cell protection/resistance against the induced injury. 
The apparent correlation between p38 and Nrf2-mediated antioxidant/detoxifying enzyme suggests 
that Nrf2 could be a downstream target of this MAPK after quercetin treatment. In this line, 
pretreatment with the p38-MAPK inhibitor prior to exposure to quercetin activated Nrf2 [40], 
which suggests that p38-MAPK signaling pathway may be implicated in the nuclear localization 
and stability of Nrf2 protein during quercetin-induced gene expression. Thus, this study 
demonstrates that p38 pathway is involved in the cell defense through the modulation of Nrf2 and 
antioxidant/detoxificant enzymes after quercetin exposure. 
In summary, the present study demonstrates that a possible mechanism of action of quercetin may 
be by regulating the GSH-related antioxidant/detoxifying enzymes. Thus, p38 is implicated in the 
modulation of Nrf2 and GSH-related enzymes in quercetin-treated cells at a shorter time than that 
causing cell damage. However, this response is impaired at longer times of incubation, when the 
toxic insult has overwhelmed the cellular defense mechanisms. These results might have 
implications for humans in terms of use of flavonoids in an attempt to support cancer 
chemotherapy. Consequently, further efforts are needed to elucidate the benefits and risks of 
flavonoids since they are used increasingly in dietary supplements. 
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Legends to figures 
 
Figure 1. Dose-dependent effects of quercetin on p38 and Nrf2 after 4 and 18 h of treatment. 
Effects on the basal levels of phosphorylated p38 (Thr180/Tyr182) and total p38 after incubating 
HepG2 cells for 4 (white bars) or 18 h (black bars). (A) Representative blots. (B) Percentage data of 
the p-p38/p38 ratio relative to controls (means  SD, n =5). Normalization of Western blots was 
ensured by -actin. Effects of quercetin on cytosolic and nuclear Nrf2 levels (100 and 57 kDa) after 
for 4 (white bars) or 18 h (black bars) treatment. (C) Bands of representative experiments. Anti-
GRB2 and anti-PARP antibodies were used as markers for the cytosolic and nuclear extracts, 
respectively. (D) Percentage values of nuclear levels of phosphorylated Nrf2 (100 kDa) relative to 
the control condition (means ± SD, n=6) (E) Nuclear/cytosolic Nrf2 (57 kDa) ratio of bands 
densitometric quantification (means  SD, n=6). Normalization of Western blots was ensured by -
actin and it was not included in the plot due to the complexity of the figure. Means without a 
common letter differ, P<0.05. 
 
Figure 2. Fluorescence images of the subcellular localization of quercetin. To visualize nuclei, 6-
diamidino-2-phenylindole (DAPI) staining was used. These results are representative of two 
independent experiments. 
 
Figure 3. Time-dependent effects of quercetin on the basal levels of phosphorylated p38 
(Thr180/Tyr182) and total p38. (A) Representative blots. (B) Percentage data of the p-p38/p38 ratio 
relative to controls (means  SD, n =7). Normalization of Western blots was ensured by -actin. 
Means without a common letter differ, P<0.05. 
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Figure 4. Time-course effects of quercetin on cytosolic and nuclear Nrf2 levels (100 and 57 kDa), 
and on DNA binding activity. (A) Bands of representative experiments. Anti-GRB2 and anti-PARP 
antibodies were used as markers for the cytosolic and nuclear extracts, respectively. (B) Percentage 
values of nuclear levels of phosphorylated Nrf2 (100 kDa) relative to the control condition (means 
± SD, n=7) (C) Nuclear/cytosolic Nrf2 (57 kDa) ratio of bands densitometric quantification (means 
 SD, n=8). Normalization of Western blots was ensured by -actin and it was not included in the 
plot due to the complexity of the figure. (D) DNA-binding activity of Nrf2 (means  SD, n=8). 
Absorbance was measured at 450 nm. Means without a common letter differ, P<0.05. 
 
Figure 5. Effects of quercetin and SB203580 (SB) plus quercetin treatments on cytosolic and 
nuclear Nrf2 levels (100 and 57 kDa), and on DNA binding activity at 4 and 18 h. HepG2 cells 
were incubated with 50 μM quercetin for 4 h or 18 h in the presence or absence of 10 μM SB. (A) 
Bands of representative experiments after 4 h treatment. (B) Percentage of 100 kDa nuclear Nrf2 
relative to control condition, (C) 57 kDa nuclear/cytosolic Nrf2 ratio (means  SD, n=5). (D) DNA-
binding activity of Nrf2 after 4 h of exposure (means  SD, n=8). (E) Representative blot after 18 h 
of exposure. (F) Values of 100 kDa nuclear Nrf2 are shown as a percent relative to the control 
condition and (G) 57 kDa nuclear/cytosolic Nrf2 ratio (means  SD, n=6). Anti-GRB2 and anti-
PARP antibodies were used as markers for the cytosolic and nuclear extracts, respectively. 
Normalization of Western blots was ensured by -actin and it was not included in the plot due to 
the complexity of the figure. (H) DNA-binding activity of Nrf2 after 18 h of incubation (means  
SD, n=8). Absorbance was measured at 450 nm. Different letters on bars denote statistically 
significant differences, P<0.05. 
 
Figure 6. Effects of quercetin, SB203580 (SB) and cycloheximide (CHX) on cytosolic and nuclear 
Nrf2 levels (57 kDa) at 18 h. HepG2 cells were incubated with 50 μM quercetin for 18 h in the 
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presence or absence of 10 μM SB and/or 100 g/mL CHX. (A) Representative blots. Anti-GRB2 
and anti-PARP antibodies, used as markers for the cytosolic and nuclear extracts, respectively. (B) 
Nrf2 nuclear/cytosolic ratio (57 kDa, means  SD, n=6). Normalization of Western blots was 
ensured by -actin, yet it was not included in the plot due to the complexity of the figure. Means 
without a common letter differ, P<0.05. 
 
Figure 7. Effects of quercetin and SB203580 (SB) plus quercetin treatments on (A) GSH levels, (B) 
GPx, (C) GR and (D) GST activities. HepG2 cells were incubated with 50 μM quercetin for 4 
(white bars) or 18 h (black bars) in the presence or absence of 10 μM SB. Values are means of eight 
to twelve different samples per condition. Different letters on bars denote statistically significant 
differences, P<0.05 
 
Figure 8. Effects of quercetin and SB203580 (SB) plus quercetin treatments on GPx, GR, GCS and 
GST mRNA levels after (A) 4 h or (C) 18 h quercetin (50 μM) exposure. Representative RT-PCR 
of three different experiments. Percentages of mRNA levels of GPx, GR, GCS and GST after (B) 4 
h or (D) 18 h (means  SD). Means without a common letter differ, P<0.05. 
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Table 1. Effect of quercetin on cell viability. HepG2 cells were treated with 50 μM 
quercetin for 4 and 18 hours, respectively and cell viability was determined as relative 
percent of crystal violet stained control cells. Data represent means  SD of 8-10 
separate experiments. Means in a column without a common letter differ, P<0.05. 
 
 
 
Quercetin 
(50 μM) 
 
Time (hours) 
 
4 h (% of viable cells) 
 
18 h (% of viable cells) 
 
C 
Q 
Q+SB 
 
100.0 ± 13.5
a
 
82.9 ± 11.3
a
 
81.6 ± 10.3
a
 
 
100.0 ± 15.1
a
 
59.1 ± 5.25
b
 
77.8 ± 8.4
c
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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Figure 8. 
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